EASD Highlights

flipper_slider

Editor's Choice

Baptist Gallwitz gives his view on the most important nonglycaemic management targets in type 2 diabetes. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING, SEPTEMBER 2016 WHICH...

EASD Highlights Videos

We are pleased to introduce Abd Tahrani as the new Editor in Chief for European Endocrinology. In this interview Dr Tahrani discusses his research interests and his aims for the journal over the next year. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING,...
Stephen Bain reviews the future of insulin pump therapy, including virtual clinics and artificial pancreas. Support: The filming of this video was supported by Cellnovo Ltd. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING, SEPTEMBER 2016 WHAT IS A VIRTUAL...
Stephen Bain talks about insulin pump therapy in the United Kingdom. Support: The filming of this video was supported by Cellnovo Ltd. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING, SEPTEMBER 2016 WHY IS THE PREVALENCE OF INSULIN PUMP THERAPY SO LOW...
Stephen Bain reviews the different types of insulin pumps and the importance of safety features. Support: The filming of this video was supported by Cellnovo Ltd. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING, SEPTEMBER 2016 WHAT KINDS OF INSULIN PUMPS...
Stephen Bain discusses insulin pump therapy and how patients feel about it. Support: The filming of this video was supported by Cellnovo Ltd. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING, SEPTEMBER 2016 WHY DO SOME PATIENTS WITH TYPE 1 DIABETES (T1DM)...
Christoph Wanner discusses the EMPA-REG study and the secondary kidney outcomes results. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING, SEPTEMBER 2016 ONE YEAR ON FROM THE PUBLICATION OF THE EMPA-REG TRIAL, HOW HAS THE DATA BEEN TAKEN UP BY THE COMMUNITY...
Solomon Tesfaye discusses the combined retinal/neuropathy/renal screening service model. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING, SEPTEMBER 2016 HOW SIGNIFICANT A PROBLEM IN THE UK IS LATE DIAGNOSIS OF DIABETES PERIPHERAL NEUROPATHY? 00:14 -...
Baptist Gallwitz gives his view on the most important nonglycaemic management targets in type 2 diabetes. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING, SEPTEMBER 2016 WHICH ARE THE MOST IMPORTANT NONGLYCAEMIC MANAGEMENT TARGETS IN TYPE 2 DIABETES? 00:14...
Rayaz Malik discusses association between vitamin D and diabetic neuropathy. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING, SEPTEMBER 2016 WHAT EVIDENCE SUPPORTS THE ASSOCIATION BETWEEN VITAMIN D LEVELS AND DIABETIC NEUROPATHY? 00:15 - So if you do a...
Guy Rutten reviews the difference in cardiovascular risk profiles of US and European participants in the LEADER trial and the need for treatment to become more patient-centred. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING, SEPTEMBER 2016 HOW DID THE...
Guy Rutten talks about the role of insulin in the management of type 2 diabetes and gives an overview of the ADDITION-Europe study. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING, SEPTEMBER 2016 IN THE ERA OF NEW ORAL AND INJECTABLE THERAPIES, WHAT IS THE...
Antonio Ceriello gives his opinion on how the results of the outcome trials will effect current treatment paradigms. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING, SEPTEMBER 2016 WHAT MECHANISMS MIGHT EXPLAIN THE RAPID EFFECT ON MORTALITY SEEN IN THE EMPA...
Antonio Ceriello discusses the possible mechanisms explaining the results of the recent outcome trials. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING, SEPTEMBER 2016 THE FINDINGS OF THE CARDIOVASCULAR OUTCOME TRIALS WERE DISAPPOINTING IN TERMS OF DPP-4...